From extending lifespan to bolstering the immune system, the drug’s effects are only just beginning to be understood.
August 1, 2013|
August 2013's selection of notable quotes
July 11, 2013|
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.
June 18, 2013|
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
June 13, 2013|
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
February 13, 2013|
As reproductive tissues age, DNA repair mechanisms become less efficient, causing genomic damage to accumulate.
December 3, 2012|
The Supreme Court agrees to hear a case deciding if two cancer genes should continue to be protected by patent.
August 17, 2012|
Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
June 19, 2012|
A public interest legal group has renewed the fight against DNA patenting.
April 1, 2012|
Genes shared across species that produce different phenotypes – deafness in humans and directional growth in plants – may reveal new models of disease.
December 22, 2011|
Mutations known to increase the risk of developing ovarian and breast cancer may also make carriers susceptible to heart failure.